Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 9, 2016, Pages 1852-1859

  Sun, N ^a   Yang, C X ^a   Liu, Z F ^a   Li, X R ^a   Xu, Y ^a   Zhang, K R ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Gene polymorphism; Major depressive disorder; Overdominant model; Serotonin transporter protein promoter

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MAJOR DEPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 85012047287     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. KENDLER KS, GATZ M, GARDNER CO, PEDERSEN NL. A Swedish national twin study of lifetime major de-pression. Am J Psychiatry 2006; 163: 109-114.
2. GÜL AI, SIMSEK G, KARAASLAN Ö, INANIR S. Compari-son of automatical thoughts among generalized anxiety disorder, major depressive disorder and generalized social phobia patients. Eur Rev Med Pharmacol Sci 2015; 15: 2916-2921.
3. KENDLER KS, AGGEN SH, NEALE MC. Evidence for multiple genetic factors underlying DSM-IV crite-ria for major depression. JAMA Psychiatry 2013; 70: 599-607.
4. FLINT J, KENDLER KS. The genetics of major depres-sion. Neuron 2014; 81: 484-503.
5. RISCH N, HERRELL R, LEHNER T, LIANG KY, EAVES L, HOH J, GRIEM A, KOVACS M, OTT J, MERIKANGAS KR. Inter-action between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009; 301: 2462-2471.
6. CASPI A, HARIRI AR, HOLMES A, UHER R, MOFFITT TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its impli-cations for studying complex diseases and traits. Am J Psychiatry 2010; 167: 509-527.
7. CLARKE H, FLINT J, ATTWOOD AS, MUNAFÒ MR. Asso-ciation of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med 2010; 40: 1767-1778.
8. ODGEREL Z, TALATI A, HAMILTON SP, LEVINSON DF, WEISSMAN MM. Genotyping serotonin trans-porter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health’s Collaborative Center for Genomic Studies. Transl Psychiatry 2013; 3: e307.
9. SAHRAIAN S, BABASHAMS M, REZA-SOLTANI P, NAJMABADI H, KAHRIZI K, GORGANI SH. Serotonin Transporter Poly-morphism (5-HTTLPR) and Citalopram Effective-ness in Iranian Patients with Major Depressive Dis-order. Iran J Psychiatry 2013; 8: 86-91.
10. MUNAFÒ MR, CLARK TG, MOORE LR, PAYNE E, WALTON R, FLINT J. Genetic polymorphisms and person-ality in healthy adults: a systematic review and meta-analysis. Mol Psychiatry 2003; 8: 471-484.
11. AUTRY AE, MONTEGGIA LM. Brain-derived neuro-trophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238-258.
12. HWANG JP, TSAI SJ, HONG CJ, YANG CH, LIRNG JF, YANG YM. The Val66Met polymorphism of the brain-de-rived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834-1837.
13. IGA J, UENO S, YAMAUCHI K, NUMATA S, TAYOSHI-SHIBUYA S, KINOUCHI S, NAKATAKI M, SONG H, HOKOISHI K, TANABE H, SANO A, OHMORI T. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 1003-1006.
14. RIBEIRO L, BUSNELLO JV, CANTOR RM, WHELAN F, WHITTAK-ER P, DELOUKAS P, WONG ML, LICINIO J. The brain-de-rived neurotrophic factor rs6265 (Val66Met) poly-morphism and depression in Mexican-Americans. Neuroreport 2007; 18: 1291-1293.
15. VERHAGEN M, VAN DER MEIJ A, VAN DEURZEN PA, JANZING JG, ARIAS-VÁSQUEZ A, BUITELAAR JK, FRANKE B. Me-ta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010; 15: 260-271.
16. GYEKIS JP, YU W, DONG S, WANG H, QIAN J, KOTA P, YANG J. No association of genetic variants in BD-NF with major depression: a meta- and gene-based analysis, Am J Med Genet B Neuropsychi-atr Genet 2013; 162B: 61-70.
17. ZHANG K, YANG C, XU Y, SUN N, YANG H, LIU J, XU Q, SHEN Y. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 2010; 117: 393-401.
18. MARTINOWICH K, LU B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsy-chopharmacology 2008; 33: 73-83.
19. ZHANG K, XU Q, XU Y, YANG H, LUO J, SUN Y, SUN N, WANG S, SHEN Y. The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese popula-tion. J Affect Disord 2009; 114: 224-231.
20. WIGGINTON JE, CUTLER DJ, ABECASIS GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 887-893.
21. MUNAFÒ MR, CLARK TG, ROBERTS KH, JOHNSTONE EC. Neuroticism mediates the association of the se-rotonin transporter gene with lifetime major de-pression. Neuropsychobiology 2006; 53: 1-8.
22. CONVERGE CONSORTIUM. Sparse whole-genome se-quencing identifies two loci for major depressive disorder. Nature 2015; 523: 588-591.
23. UENO S. Genetic polymorphisms of serotonin and dopamine transporters in mental disorders. J Med Invest 2003; 50: 25-31.
24. REYNOLDS GP, MCGOWAN OO, DALTON CF. Pharma-cogenomics in psychiatry: the relevance of re-ceptor and transporter polymorphisms. Br J Clin Pharmacol 2014; 77: 654-672.
25. BALDING DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7: 781-791.
26. DJALALI S, HÖLTJE M, GROSSE G, ROTHE T, STROH T, GROSSE J, DENG DR, HELLWEG R, GRANTYN R, HÖRTNAGL H, AHNERT-HILGER G. Effects of brain-derived neu-rotrophic factor (BDNF) on glial cells and sero-tonergic neurones during development. J Neuro-chem 2005; 92: 616-627.
27. HOMBERG JR, MOLTENI R, CALABRESE F, RIVA MA. The serotonin-BDNF duo: developmental implica-tions for the vulnerability to psychopathology. Neurosci Biobehav Rev 2014; 43: 35-47.
28. CASTRÉN E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 2004; 4: 58-64.
29. LEE KY, JEONG SH, KIM SH, AHN YM, KIM YS, JUNG HY, BANG YW, JOO EJ. Genetic role of BDNF Val66Met and 5-HTTLPR polymorphisms on depressive disorder. Psychiatry Investig 2014; 11: 192-199.
30. GRABE HJ, SCHWAHN C, MAHLER J, APPEL K, SCHULZ A, SPITZER C, FENSKE K, BARNOW S, FREYBERGER HJ, TEUMER A, PETERSMANN A, BIFFAR R, ROSSKOPF D, JOHN U, VÖLZKE H. Genetic epistasis between the brain-derived neurotrophic factor Val-66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 264-270.
31. GUTIÉRREZ B, BELLÓN JÁ, RIVERA M, MOLINA E, KING M, MARSTON L, TORRES-GONZÁLEZ F, MORENO-KÜSTNER B, MORENO-PERAL P, MOTRICO E, MONTÓN-FRANCO C, GIL-DEGÓMEZ-BARRAGÁN MJ, SÁNCHEZ-CELAYA M, DÍAZ-BAR-REIROSMÁ, VICENS C, DE DIOSLUNA J, NAZARETH I, CER-VILLA J. The risk for major depression conferred by childhood maltreatment is multiplied by BD-NF and SERT genetic vulnerability: a replication study. J Psychiatry Neurosci 2015; 40: 187-196.
32. HARKNESS KL, STRAUSS J, MICHAEL BAGBY R, STEWART JG, LAROCQUE C, MAZURKA R, RAVINDRAN A, WYNNE-EDWARDSKE5, RECTOR NA6, KENNEDY J2. Interactions between childhood maltreatment and brain-derived neuro-trophic factor and serotonin transporter polymor-phisms on depression symptoms. Psychiatry Res 2015; 229: 609-612.